Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Esketamine on Delayed Neurocognitive Recovery in Older Patients Undergoing Non-cardiac Surgery
NCT07523334Phase 4Not yet recruiting
- Sponsor
- Peking University First Hospital
- Start
- Apr 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esketamine in Post-operative cognitive dysfunction (POCD), postoperative delirium (POD), sponsored by Peking University First Hospital. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Post-operative cognitive dysfunction (POCD)postoperative delirium (POD)
Beyond the preview
Go deeper on NCT07523334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07523334.